Functional rescue of cone photoreceptors in retinitis pigmentosa.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

15 citing papers in PubMed.

1. Management of retinitis pigmentosa by Wharton's jelly-derived mesenchymal stem cells: prospective analysis of 1-year results.Stem cell research & therapy · 2020
   Trial
2. Effects of subtenon-injected autologous platelet-rich plasma on visual functions in eyes with retinitis pigmentosa: preliminary clinical results.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2018
   Trial
3. [Optogenetic reactivation of dormant cone photoreceptors].Die Ophthalmologie · 2026
   Article
4. Combined Expression of hRdCVF and hRdCVFL Through AAV-Mediated Delivery for the Treatment of Retinitis Pigmentosa.Investigative ophthalmology & visual science · 2026
   Article
5. PEGDA-based HistoBrick for increasing throughput of cryosectioning and immunohistochemistry in organoid and small tissue studies.Scientific reports · 2025
   Article
6. Suprachoroidal spheroidal mesenchymal stem cell implantation in retinitis pigmentosa: clinical results of 6 months follow-up.Stem cell research & therapy · 2023
   Article
7. Optogenetic Therapy for Visual Restoration.International journal of molecular sciences · 2022
   Review
8. Is Nucleoredoxin a Master Regulator of Cellular Redox Homeostasis? Its Implication in Different Pathologies.Antioxidants (Basel, Switzerland) · 2022
   Review
9. Advancing precision medicines for ocular disorders: Diagnostic genomics to tailored therapies.Frontiers in medicine · 2022
   Review
10. Light responses of mammalian cones.Pflugers Archiv : European journal of physiology · 2021
    Review
11. Metabolic and Redox Signaling of the Nucleoredoxin-Like-1 Gene for the Treatment of Genetic Retinal Diseases.International journal of molecular sciences · 2020
    Review
12. Management of retinitis pigmentosa by Wharton's jelly derived mesenchymal stem cells: preliminary clinical results.Stem cell research & therapy · 2020
    Article
13. Restoration of Cone Photoreceptor Function in Retinitis Pigmentosa.Translational vision science & technology · 2017
    Review
14. Two-Step Reactivation of Dormant Cones in Retinitis Pigmentosa.Cell reports · 2016
    Article
15. Prevalence of night blindness in Bashagard district in Hormozgan, Iran, in 2011.Electronic physician
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

10 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as